Ken Griffin Charles River Laboratories International, Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $3.14 Million - $4.08 Million	-15,200 Reduced 21.68%	54,900 $11.3 Million
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $5.01 Million - $6.73 Million	24,600 Added 54.07%	70,100 $19 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $3.55 Million - $5.16 Million	21,600 Added 90.38%	45,500 $10.8 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $3.58 Million - $4 Million	18,400 Added 334.55%	23,900 $4.68 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $349,049 - $399,475	-1,900 Reduced 25.68%	5,500 $1.16 Million
Q1 2023 May 15, 2023	SELL	$191.89 - $259.92 $3.63 Million - $4.91 Million	-18,900 Reduced 71.86%	7,400 $1.49 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $3.17 Million - $4.03 Million	16,100 Added 157.84%	26,300 $5.73 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $2.1 Million - $2.88 Million	-11,500 Reduced 53.0%	10,200 $2.01 Million

732

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.7B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.